Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:
RSNA 2020 is in the books, but that does not mean coverage on Diagnostic Imaging stops. The conference still has a great deal to offer. Later this week, look for the third, and final, installment of videos with David Larson, M.D., professor of radiology at Stanford University, focusing on the ethical questions and challenges surrounding the use of artificial intelligence with patient data and medical imaging.
For the previous two videos with Larson, as well as other RSNA 2020 coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
As the country rounds into the holidays and toward the New Year, cases of COVID-19 are, once again, surging. That makes it all the more critical for providers to be able to identify patients who are infected with the virus and, potentially, learn who will fare better or worse. New research is out this week focusing on this issue – Diagnostic Imaging will report on the role imaging plays later this week.
For additional reporting on the use of imaging to diagnose and assess COVID-19 patients, click here.
Since March, 2020 has been a rough, demanding year, putting radiology in the middle of the worst healthcare crisis seen in a century. But, dealing with the pandemic is not the only health-related event throughout the past 12 months. While radiologists and other healthcare providers were focused on the emergent needs, advancements were still marching on in other areas of medical imaging. This week, Diagnostic Imaging will share some the biggest developments of the year in mammography.
For additional mammography coverage, click here.
Study Says Contrast-Enhanced Mammography Offers Comparable Breast Cancer Detection to MRI
November 15th 2023In findings from an enriched cohort of asymptomatic patients with screening-detected abnormalities, researchers found that contrast-enhanced mammography (CEM) was superior to conventional mammography and offered equivalent detection of breast cancer in comparison to breast MRI and abbreviated breast MRI.
What a New Review Reveals About Mammography-Based AI and Breast Cancer Risk Assessment
November 9th 2023Mammography-based artificial intelligence (AI) models demonstrated an 11 percent higher median AUC for predicting breast cancer than traditional clinical risk factors, according to a new systematic review of 16 retrospective studies.
Outpatient Reimbursement to Increase 65 Percent for EchoGo Heart Failure Platform in 2024
November 8th 2023Reimbursement for use of the artificial intelligence (AI)-powered EchoGo Heart Failure platform in hospital outpatient settings for Medicare and Medicaid patients is expected to increase from $99.81 to $284.88 in 2024.